NCT01410942 2026-02-20
Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
27 trialsNCT01628029 2026-02-04
Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06905587 2025-12-11
EMBRAIN
Odense University Hospital
Phase 3 Recruiting
NCT05474846 2025-11-06
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2/3 Recruiting
NCT03525873 2025-10-20
A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy
M.D. Anderson Cancer Center
Phase 3 Active not recruiting
NCT03772834 2025-10-10
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
NCT00424099 2023-06-01
Methylphenidate and a Nursing Telephone Intervention for Fatigue
M.D. Anderson Cancer Center
Phase 2/3 Completed
NCT02970500 2023-03-23
CogMet
CHU de Quebec-Universite Laval
Phase 2 Terminated
NCT05041946 2022-09-29
Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial
M.D. Anderson Cancer Center
Phase 3 Completed
NCT02361125 2022-01-04
Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00418691 2020-09-23
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01164956 2019-04-26
Methylphenidate for Cancer-Related Fatigue
Dana-Farber Cancer Institute
Phase 1 Terminated
NCT03218254 2018-12-05
MICRO
Odense University Hospital
Phase 3 Unknown
NCT00516269 2018-01-03
Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00576472 2017-05-30
Learning Impairments Among Survivors of Childhood Cancer
St. Jude Children's Research Hospital
Phase 4 Completed
NCT01773837 2017-05-09
Clinical Trial to Evaluate Short-term Efficacy of Palliative Methylphenidate in Asthenia in Advanced Cancer Patients
Clinica Universidad de Navarra, Universidad de Navarra
Phase 3 Terminated
NCT00376675 2016-08-01
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00129467 2015-04-24
Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
VA Office of Research and Development
Phase NA Completed
NCT01100658 2015-03-27
Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
University of Minnesota
Phase NA Terminated
NCT00593853 2014-06-04
Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy
University Health Network, Toronto
Phase 2 Terminated
NCT01348607 2014-02-21
Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy
University of South Florida
Phase 2 Terminated
NCT00069927 2014-02-03
Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression
University of South Florida
Phase 2 Terminated
NCT01497548 2011-12-22
Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients
University of Malaya
Phase 3 Unknown
NCT00169611 2011-01-27
NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
Hospices Civils de Lyon
Phase 4 Completed
NCT00758407 2010-01-13
EMF
Medice Arzneimittel Pütter GmbH & Co KG
Phase 2/3 Completed
NCT00273741 2009-12-07
Ritaline
University Hospital, Grenoble
Phase 3 Terminated
NCT00138138 2007-12-10
Psychostimulants for Fatigue in Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed